Detalles de la búsqueda
1.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
Int Braz J Urol
; 47(2): 359-373, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284538
2.
Oncology Clinical Trials During the COVID-19 Pandemic.
Oncology (Williston Park)
; 34(7): 265-269, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32674214
3.
Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development.
Curr Oncol Rep
; 22(7): 70, 2020 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32529490
4.
Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis.
Clin Genitourin Cancer
; 22(3): 102088, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718699
5.
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
J Cancer Res Clin Oncol
; 150(4): 183, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594593
6.
PD-L1 gene amplification and focality: relationship with protein expression.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849197
7.
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
Clin Genitourin Cancer
; 21(3): e104-e113, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36509612
8.
Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysis.
Transl Oncol
; 19: 101383, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248919
9.
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective.
J Med Econ
; 24(1): 291-298, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33538203
10.
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
JCO Glob Oncol
; 7: 545-549, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33856892
11.
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome.
JCO Glob Oncol
; 7: 1141-1150, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34270331
12.
Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol
; 7: 559-571, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33856891
13.
Impact of the biomarker enrichment strategy in drug development.
Expert Rev Mol Diagn
; 20(6): 611-618, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903795
14.
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
J Cancer Res Clin Oncol
; 146(7): 1829-1845, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410064
15.
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery.
Ther Adv Urol
; 11: 1756287219872324, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523281
16.
An appraisal of drug development timelines in the Era of precision oncology.
Oncotarget
; 7(33): 53037-53046, 2016 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27419632
17.
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer.
Oncotarget
; 7(39): 64431-64446, 2016 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26824988
18.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities
Int. braz. j. urol
; 47(2): 359-373, Mar.-Apr. 2021. tab
Artículo
en Inglés
| LILACS | ID: biblio-1154467
19.
Expression of Sara2 human gene in erythroid progenitors.
J Biochem Mol Biol
; 38(3): 328-33, 2005 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-15943909
20.
Phase I trials of antitumour agents: fundamental concepts.
Ecancermedicalscience
; 9: 501, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25729414